Skip to main content

Table 1 Clinicopathologic features of colorectal cancer patients (CRC) of the Humanitas Cohort

From: Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer

Cases

40 CRC

Gender

 Male

25

 Female

15

Median age (years, range)

71 (35–81)

Site

 Colon right

16 (40%)

 Colon left

11 (27,5%)

 Rectum

13 (32,5%)

Histology

 Mucinous

2 (5%)

 Adenocarcinoma

38 (95%)

TNM staging system

 Primary tumor (T)

  T1

8 (20%)

  T2

12 (30%)

  T3

11 (27.5%)

  T4

9 (22.5%)

 Regional lymph nodes (N)

 

  N0

30 (75%)

  N1

6 (15%)

  N2

4 (10%)

 Distant metastases (M)

  M0

40 (100%)

  M1

0

 Chemotherapy/ neoadjuvant

  No

40 (100%)

  yes

0 (0%)

  KRAS mut

14 (35%)

  KRAS wilde type

7 (17,5%)

  BRAF mut

2 (5%)

  BRAF wild type

38 (95%)